Navigation Links
Rare Fungus Infection, Not Due to Our Products, Says Bausch & Lomb

Bausch & Lomb Inc. is in the eye of a storm. Now, the company is working in conjunction with health professionals to ascertain the reason// behind a strange fungus infection among contact lens wearers. This infection initially cropped up in certain parts of Asia.

Bausch & Lomb, who are producers of both contact lenses and lens solution, feels that the cause of Fusarium keratitis infections is not emanating from the product or the solution. ReNU solution apparently caused the problem amongst its users in both Hong Kong and Singapore. The company has also faced requests to remove the product from the shelves, though a spokeswoman confirmed that the testing of the solution did not show any problem .The company have also conducted detailed tests on the product, and there has been no indication that the product or the solution has caused the infection.

The negative publicity due to the alleged infection in lens has caused a slump in sales, especially in China, despite no infections reported from there. Bausch & Lomb said that the U.S. Centers for Disease Control and Prevention and health ministries in Singapore, Hong Kong, and Malaysia, as well as eye institutes at the University of Miami and Johns Hopkins University’s are working along with the company to investigate these infections.


'"/>




Page: 1

Related medicine news :

1. Diabetics Need to Guard Against Nail Fungus
2. Fight against Fungus - A new ray of hope
3. Eye Hygiene Crucial To Keep Fungus at Bay
4. Cancer-Killing Compound From A Fungus
5. Tips for Avoiding Foot Fungus in Communal Bathrooms
6. Day Care Centres Possibly Give Rise to More Infection, an Australian Study
7. Bausch & Lomb Pulls Lens Solution From US Market
8. Bausch & Lomb Facility under Scrutiny
9. Bausch & Lomb Launches New Vision Correction Technology
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... ... March 23, 2017 , ... Ogden Clinic, the largest ... centric payment system, to expand its focus on patient care by providing an ... , “At Ogden Clinic, we are working to become a different type ...
(Date:3/23/2017)... ... 23, 2017 , ... “The Trainer”: an electrifying and suspenseful gunslinger novel ... writer with an active imagination and an enthusiasm for action and adventure stories. ... Wild Bill Hart, who sat looking at the thirty-three notches that lined the edges ...
(Date:3/23/2017)... ... March 23, 2017 , ... Vortex Biosciences, provider of circulating ... in circulating tumor cells using microfluidic western blotting” in Nature Communications on March ... technology to capture CTCs and a microfluidic single-CTC resolution Western blot from ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... publication of the first issue of its companion print magazine. The new magazine, ... cosmetic surgery thanks to information provided by board-certified doctors from across the country. ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... California Bay Area providing insurance assistance, financial planning, and related services to residents ... Species International to promote awareness of threatened species and wild lands. , Endangered ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... March 23, 2017 On ... the trading session at 5,821.64, up 0.48%; the ... finish at 20,661.30; and the S&P 500 closed ... based as six out of nine sectors ended ... initiated reports coverage on the following Medical Instruments ...
(Date:3/23/2017)... , March 23, 2017 BioLineRx Ltd. ... immunology, announced today that it has acquired Agalimmune Ltd., a ... consideration consisted of a $6 million upfront payment, of which ... shares. Additional future payments may be made based on development ... ...
(Date:3/23/2017)... AVIV, Israel, March 23, 2017  Galmed Pharmaceuticals ... the "Company"), a clinical-stage biopharmaceutical company focused on ... the treatment of nonalcoholic steatohepatitis, or NASH, and ... the three and twelve months ended December 31, 2016, ... completed pre-clinical studies demonstrating Aramchol™,s potential direct effect ...
Breaking Medicine Technology: